Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Albemarle reports second quarter 2013 results

      Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation) (PRNewsFoto/)

      News provided by

      Albemarle Corporation

      Jul 17, 2013, 04:38 ET

      Share this article

      Share this article


      BATON ROUGE, La., July 17, 2013 /PRNewswire/ --

      Second quarter 2013 highlights:

      • Earnings of $81.8 million, or $0.97 per share, excluding non-operating items.
      • Net sales of $634 million and EBITDA margin, excluding non-operating items, of 22 percent.
      • Announced $450 million accelerated share repurchase program and repurchased approximately 6.8 million shares in second quarter.
      • Announced agreement to establish a Chinese joint venture to produce MARTINAL® flame retardants.

      Three Months Ended


      Six Months Ended



      June 30,


      June 30,


      In thousands, except per share amounts

      2013


      2012


      2013


      2012















      Net sales

      $

      634,197


      $

      684,894


      $

      1,275,822


      $

      1,396,598















      Segment income

      $

      129,031


      $

      179,710


      $

      262,656


      $

      359,473















      Net income attributable to Albemarle Corporation

      $

      82,739


      $

      50,089


      $

      166,726


      $

      164,351















      Diluted earnings per share

      $

      0.98


      $

      0.56


      $

      1.92


      $

      1.83















         Non-operating pension and OPEB items(a)


      (0.01)



      (0.09)



      (0.03)



      (0.11)


         Special items(b)


      —



      0.82



      —



      0.82















      Diluted earnings per share, excluding special and













       non-operating pension and OPEB items(e)

      $

      0.97


      $

      1.28


      $

      1.89


      $

      2.53
















      See accompanying notes and reconciliations to the condensed consolidated financial information.

      (Logo: http://photos.prnewswire.com/prnh/20111129/MM14279LOGO)

      Albemarle Corporation (NYSE: ALB) reported second quarter 2013 earnings of $82.7 million, or $0.98 per share, compared to second quarter 2012 earnings of $50.1 million, or $0.56 per share.  Excluding special and non-operating pension and OPEB items (see notes to the condensed consolidated financial information), second quarter 2013 earnings were $81.8 million, or $0.97 per share, compared to $115.3 million, or $1.28 per share, for the second quarter of 2012.  The Company reported net sales of $634.2 million in the second quarter of 2013, down from net sales of $684.9 million in the second quarter of 2012, driven by our exit from the phosphorus flame retardants business, lower metals surcharges, unfavorable pricing in our bromine portfolio and lower Fine Chemistry Services volumes, partly offset by favorable volumes in our Refinery Catalysts and Brominated Flame Retardant businesses.

      Earnings for the first half of 2013 were $166.7 million, or $1.92 per share, compared to $164.4 million, or $1.83 per share, for the first half of 2012.  Excluding special and non-operating pension and OPEB items, earnings for the first half of 2013 were $164.5 million, or $1.89 per share, compared to $227.8 million, or $2.53 per share, for the first half of 2012.  Net sales for the first half of 2013 were $1.28 billion, down from $1.40 billion for the first half of 2012, driven by lower metals surcharges and pricing on certain products. 

      "Our businesses delivered EBITDA margins of 22% in spite of facing lower metals surcharges and an economic environment which saw continued sluggishness across Europe, weak electronics and construction markets and a much weaker China than most anticipated at the beginning of the year," stated Luke Kissam, CEO.  "We also successfully met several key milestones with regard to bringing on our bromine and organometallics expansions, which will be essential drivers of our long term growth."

      Quarterly Segment Results

      Catalysts generated net sales of $233.8 million in the second quarter of 2013, a 2 percent increase from net sales in the second quarter of 2012, with favorable volumes in Refinery Catalysts Solutions being largely offset by lower metals surcharges and lower Performance Catalyst Solutions volumes.  Catalysts segment income was $51.0 million in the second quarter of 2013, down 25 percent from second quarter 2012 results of $68.2 million, due primarily to lower metals surcharges and higher manufacturing costs. 

      Polymer Solutions reported net sales of $224.3 million in the second quarter of 2013, a 9 percent decrease from net sales in the second quarter of 2012, due to the year-over-year effects of our phosphorus flame retardants business exit in the second quarter of 2012 and overall lower flame retardant pricing, partly offset by favorable flame retardants volumes.  Segment income for Polymer Solutions was $43.7 million in the second quarter of 2013, a 34 percent decline from $65.7 million in the second quarter of 2012, driven by unfavorable pricing, manufacturing costs and foreign currency impacts, partly offset by favorable sales volumes and favorable impacts from our exit of the phosphorus flame retardants business.

      Fine Chemistry net sales in the second quarter of 2013 were $176.1 million, a 16 percent decrease from net sales in the second quarter of 2012, due mainly to unfavorable sales volumes and pricing.  Segment income for Fine Chemistry was $34.4 million for the second quarter of 2013, down 25 percent from second quarter 2012 results of $45.9 million, due to unfavorable pricing, lower factory operating rates and timing of custom services projects.

      Corporate and Other

      Corporate and other expense was $15.5 million ($17.1 million excluding non-operating pension and OPEB items) for the second quarter of 2013.  The $11.7 million increase from the comparable period in 2012 was due primarily to an unfavorable variance in non-operating pension and OPEB items.

      Interest and financing expenses were $7.6 million for the second quarter of 2013 compared to $8.5 million for the second quarter of 2012, with this decrease due primarily to lower interest rates on variable-rate borrowings and higher capitalized interest year-over-year.

      Excluding special and non-operating pension and OPEB items, our effective income tax rates were 20.6 percent and 26.4 percent for the second quarter of 2013 and 2012, respectively.  Our effective tax rate continues to be influenced by the level and geographic mix of income, and benefits from a favorable mix of income in lower tax jurisdictions. 

      Cash Flow

      Our cash flow from operations was approximately $179 million for the six months ended June 30, 2013, and we had $315 million in cash and cash equivalents at June 30, 2013.  During the six months ended June 30, 2013, proceeds from borrowings, cash on hand and cash provided by operations funded capital expenditures for plant, machinery and equipment of approximately $103 million (which includes approximately $32 million in capital expenditures associated with our Jordanian joint venture), dividends to shareholders of $39.0 million and $582.3 million for repurchases of our common stock pursuant to the terms of our share repurchase program and the accelerated share repurchase program.

      Earnings Call

      The Company's performance for the second quarter ended June 30, 2013 will be discussed on a conference call at 9:00 AM Eastern Daylight time on July 18, 2013.  The call can be accessed by dialing 888-713-4211 (International Dial-In # 617-213-4864), and entering conference ID 51619577.  The Company's earnings presentation and supporting material can be accessed through Albemarle's website under Investors at www.albemarle.com.


      About Albemarle

      Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services.  Albemarle is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry, with Corporate Responsibility Magazine naming Albemarle among its prestigious "100 Best Corporate Citizens" list for 2013.  The Company employs more than 4,000 people worldwide and serves customers in approximately 100 countries.  Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings and other information regarding the Company, its businesses and markets served. 

      Forward-Looking Statements

      Some of the information presented in this press release and the conference call and discussions that follow, including, without limitation, statements with respect to product development, changes in productivity, market trends, price, volume and mix changes, expected growth and earnings, input costs, surcharges, tax rates, stock repurchases, dividends, economic trends, outlook and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  There can be no assurance that actual results will not differ materially.  Factors that could cause actual results to differ materially include, without limitation: changes in economic and business conditions; changes in financial and operating performance of our major customers and industries and markets served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; changes in the cost of raw materials and energy and in our ability to pass through such increases; acquisitions and divestitures, and changes in performance of acquired companies; changes in our markets in general; fluctuations in foreign currencies; changes in laws and government regulation impacting our operations or our products; the occurrence of claims or litigation; the occurrence of natural disasters; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest affecting the global economy, including adverse effects from terrorism or hostilities; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings and changes in tax laws and rates; changes in monetary policies, inflation or interest rates that may impact our ability to raise capital or increase our cost of funds, impact the performance of our pension fund investments and increase our pension expense and funding obligations; volatility and substantial uncertainties in the debt and equity markets; technology or intellectual property infringement, including cyber security breaches, and other innovation risks; decisions we may make in the future; and the other factors detailed from time to time in the reports we file with the SEC, including those described under "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. 


      Albemarle Corporation and Subsidiaries
      Consolidated Statements of Income
      (In Thousands Except Per Share Amounts) (Unaudited)









      Three Months Ended



      Six Months Ended



      June 30,



      June 30,



      2013



      2012



      2013



      2012


      Net sales

      $

      634,197



      $

      684,894



      $

      1,275,822



      $

      1,396,598


      Cost of goods sold


      437,558




      435,606




      879,593




      896,330


      Gross profit


      196,639




      249,288




      396,229




      500,268


      Selling, general and administrative expenses(c)


      62,900




      61,735




      127,650




      135,739


      Research and development expenses


      21,565




      20,911




      41,518




      39,960


      Restructuring and other charges, net(b)


      —




      94,703




      —




      94,703


      Operating profit


      112,174




      71,939




      227,061




      229,866


      Interest and financing expenses


      (7,608)




      (8,486)




      (12,839)




      (17,220)


      Other expenses, net


      (1,697)




      (688)




      (5,906)




      (806)


      Income before income taxes and equity in net
















         income of unconsolidated investments


      102,869




      62,765




      208,316




      211,840


      Income tax expense


      21,450




      21,882




      47,642




      60,910


      Income before equity in net income of
















         unconsolidated investments


      81,419




      40,883




      160,674




      150,930


      Equity in net income of unconsolidated
















         investments (net of tax)


      9,709




      12,712




      19,970




      21,298


      Net income


      91,128




      53,595




      180,644




      172,228


      Net income attributable to noncontrolling interests


      (8,389)




      (3,506)




      (13,918)




      (7,877)


      Net income attributable to Albemarle Corporation

      $

      82,739



      $

      50,089



      $

      166,726



      $

      164,351


















      Basic earnings per share

      $

      0.98



      $

      0.56



      $

      1.93



      $

      1.84


      Diluted earnings per share

      $

      0.98



      $

      0.56



      $

      1.92



      $

      1.83


      Weighted-average common shares outstanding –
















         basic


      84,028




      89,414




      86,374




      89,206


      Weighted-average common shares outstanding –
















         diluted


      84,489




      90,051




      86,862




      89,999


















      See accompanying notes to the condensed consolidated financial information.



      Albemarle Corporation and Subsidiaries

      Condensed Consolidated Balance Sheets

      (In Thousands) (Unaudited)









      June 30,



      December 31,



      2013



      2012


      ASSETS








      Cash and cash equivalents

      $

      314,659



      $

      477,696


      Other current assets


      967,219




      929,617










      Total current assets


      1,281,878




      1,407,313










      Property, plant and equipment


      2,895,949




      2,818,604


      Less accumulated depreciation and amortization


      1,562,184




      1,522,033


      Net property, plant and equipment


      1,333,765




      1,296,571










      Other assets and intangibles


      720,306




      733,407


      Total assets

      $

      3,335,949



      $

      3,437,291










      LIABILITIES AND EQUITY








      Current portion of long-term debt

      $

      9,355



      $

      12,700


      Other current liabilities


      366,228




      372,309










      Total current liabilities


      375,583




      385,009










      Long-term debt


      1,067,852




      686,588


      Other noncurrent liabilities


      358,647




      370,318


      Deferred income taxes


      68,474




      63,368


      Albemarle Corporation shareholders' equity


      1,352,994




      1,833,598


      Noncontrolling interests


      112,399




      98,410


      Total liabilities & equity

      $

      3,335,949



      $

      3,437,291










      See accompanying notes to the condensed consolidated financial information.



       


      Albemarle Corporation and Subsidiaries

      Selected Consolidated Cash Flow Data

      (In Thousands) (Unaudited)






      Six Months Ended



      June 30,



      2013


      2012









      Cash and cash equivalents at beginning of year

      $

      477,696


      $

      469,416


      Cash and cash equivalents at end of period

      $

      314,659


      $

      461,751









      Sources of cash and cash equivalents:














        Net income

      $

      180,644


      $

      172,228









        Proceeds from borrowings of long-term debt


      117,000



      2,978









        Proceeds from other borrowings, net


      266,248



      7









        Proceeds from exercise of stock options


      3,917



      13,430









      Uses of cash and cash equivalents:














        Capital expenditures


      (103,168)



      (126,623)









        Repurchases of common stock


      (582,298)



      (13,695)









        Repayments of long-term debt


      (6,380)



      (11,754)









        Dividends paid to shareholders


      (39,049)



      (33,399)









        Pension and postretirement contributions


      (4,246)



      (4,612)









      Non-cash and other items:














        Depreciation and amortization


      51,817



      49,449









        Non-cash charges associated with restructuring and other, net


      —



      70,587









        Pension and postretirement expense (benefit)


      3,152



      (10,203)









        Equity in net income of unconsolidated investments


      (19,970)



      (21,298)




      See accompanying notes to the condensed consolidated financial information.


      Albemarle Corporation and Subsidiaries

      Consolidated Summary of Segment Results

      (In Thousands) (Unaudited) 









      Three Months Ended



      Six Months Ended



      June 30,



      June 30,



      2013



      2012



      2013



      2012


      Net sales:
















      Polymer Solutions

      $

      224,316



      $

      247,016



      $

      439,090



      $

      475,147


      Catalysts


      233,818




      229,144




      469,391




      522,666


      Fine Chemistry


      176,063




      208,734




      367,341




      398,785


      Total net sales

      $

      634,197



      $

      684,894



      $

      1,275,822



      $

      1,396,598


















      Segment operating profit:
















      Polymer Solutions

      $

      43,821



      $

      63,407



      $

      87,491



      $

      117,954


      Catalysts


      43,613




      57,370




      92,658




      134,011


      Fine Chemistry


      40,277




      49,704




      76,455




      94,067


      Total segment operating profit


      127,711




      170,481




      256,604




      346,032


















      Equity in net income of unconsolidated investments:
















      Polymer Solutions


      2,328




      1,913




      4,636




      3,758


      Catalysts


      7,381




      10,799




      15,334




      17,540


      Fine Chemistry


      —




      —




      —




      —


      Corporate & other


      —




      —




      —




      —


      Total equity in net income of unconsolidated investments


      9,709




      12,712




      19,970




      21,298


















      Net (income) loss attributable to noncontrolling interests:
















      Polymer Solutions


      (2,494)




      349




      (3,202)




      (653)


      Catalysts


      —




      —




      —




      —


      Fine Chemistry


      (5,895)




      (3,832)




      (10,716)




      (7,204)


      Corporate & other


      —




      (23)




      —




      (20)


      Total net income attributable to noncontrolling interests


      (8,389)




      (3,506)




      (13,918)




      (7,877)


















      Segment income:
















      Polymer Solutions


      43,655




      65,669




      88,925




      121,059


      Catalysts


      50,994




      68,169




      107,992




      151,551


      Fine Chemistry


      34,382




      45,872




      65,739




      86,863


      Total segment income


      129,031




      179,710




      262,656




      359,473


      Corporate & other(a) (d)


      (15,537)




      (3,862)




      (29,543)




      (21,483)


      Restructuring and other charges, net(b)


      —




      (94,703)




      —




      (94,703)


      Interest and financing expenses


      (7,608)




      (8,486)




      (12,839)




      (17,220)


      Other expenses, net


      (1,697)




      (688)




      (5,906)




      (806)


      Income tax expense


      (21,450)




      (21,882)




      (47,642)




      (60,910)


      Net income attributable to Albemarle Corporation

      $

      82,739



      $

      50,089



      $

      166,726



      $

      164,351


      See accompanying notes to the condensed consolidated financial information.      


      Notes to the Condensed Consolidated Financial Information

      (a)   Non-operating pension and OPEB items, consisting of mark-to-market (MTM) actuarial gains/losses as well as interest costs and expected return on assets, are included in Corporate & other as follows:

      • For the three months ended June 30, 2013 and 2012, net benefits amounting to $1.5 million ($0.9 million after income taxes, or $0.01 per share) and $13.3 million ($8.4 million after income taxes, or $0.09 per share), respectively.  There were no MTM actuarial gains/losses recorded during the three months ended June 30, 2013.
      • For the six months ended June 30, 2013 and 2012, net benefits amounting to $3.6 million ($2.2 million after income taxes, or $0.03 per share) and $16.0 million ($10.1 million after income taxes, or $0.11 per share), respectively.  There were no MTM actuarial gains/losses recorded during the six months ended June 30, 2013.

      Although non-operating pension and OPEB items are included in our GAAP operating profit, we believe that these components of pension cost are mainly driven by market performance, and we manage these separately from the operational performance of our businesses.

      (b)   The three and six month periods ended June 30, 2012 include net charges amounting to $94.7 million ($73.6 million after income taxes, or $0.82 per share) in connection with our exit of the phosphorus flame retardants business. 

      (c)   The six month period ended June 30, 2012 includes a gain of $8.1 million ($5.1 million after tax, or $0.06 per share) resulting from proceeds received in connection with the settlement of litigation (net of related legal fees).  The six month period ended June 30, 2012 also includes an $8 million charitable contribution ($5.1 million after tax, or $0.06 per share) to the Albemarle Foundation. 

      (d)   The three month and six month periods ended June 30, 2013 include costs of $3.6 million which are the subject of a claim by the Company against a freight services vendor for alleged fraud committed against several companies. 

      (e)   Totals may not add due to rounding. 

      Additional Information

      It should be noted that Net income attributable to Albemarle Corporation ("earnings"), earnings per share and effective income tax rates which exclude special and non-operating pension and OPEB items, as well as presentations of segment operating profit, segment income, EBITDA, EBITDA excluding special and non-operating pension and OPEB items, EBITDA margin and EBITDA margin excluding special and non-operating pension and OPEB items are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP.  These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance.

      A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, can be found in the Investors section of our website at www.albemarle.com, under "Non-GAAP Reconciliations" under "Financials."  Also, see attached for a supplemental reconciliation of our segment operating profit and segment income amounts to GAAP Operating profit and GAAP Net income attributable to Albemarle Corporation, respectively, as well as for a supplemental reconciliation of Net income attributable to Albemarle Corporation excluding special and non-operating pension and OPEB items, EBITDA and EBITDA excluding special and non-operating pension and OPEB items to Net income attributable to Albemarle Corporation.

      ALBEMARLE CORPORATION AND SUBSIDIARIES

      Non-GAAP Reconciliation

      (In Thousands)

      (Unaudited)

      Our segment information includes measures we refer to as "segment operating profit," "segment income," "EBITDA" and "EBITDA excluding special and non-operating pension and OPEB items," which are financial measures that are not required by, or presented in accordance with, GAAP.  The Company has reported segment operating profit, segment income, EBITDA and EBITDA excluding special and non-operating pension and OPEB items because management believes that these financial measures provide transparency to investors and enable period-to-period comparability of financial performance.  Segment operating profit, segment income, EBITDA and EBITDA excluding special and non-operating pension and OPEB items should not be considered as alternatives to operating profit or net income attributable to Albemarle Corporation, as determined in accordance with GAAP.

      See below for a reconciliation of segment operating profit and segment income, the non-GAAP financial measures, to Operating profit and Net income attributable to Albemarle Corporation, respectively, the most directly comparable financial measures calculated and reported in accordance with GAAP.


      Three Months Ended


      Six Months Ended



      June 30,


      June 30,



      2013


      2012


      2013


      2012















      Total segment operating profit

      $

      127,711


      $

      170,481


      $

      256,604


      $

      346,032


      Corporate & other *


      (15,537)



      (3,839)



      (29,543)



      (21,463)


      Restructuring and other charges, net


      —



      (94,703)



      —



      (94,703)


      GAAP Operating profit

      $

      112,174


      $

      71,939


      $

      227,061


      $

      229,866















      Total segment income

      $

      129,031


      $

      179,710


      $

      262,656


      $

      359,473


      Corporate & other


      (15,537)



      (3,862)



      (29,543)



      (21,483)


      Restructuring and other charges, net


      —



      (94,703)



      —



      (94,703)


      Interest and financing expenses


      (7,608)



      (8,486)



      (12,839)



      (17,220)


      Other expenses, net


      (1,697)



      (688)



      (5,906)



      (806)


      Income tax expense


      (21,450)



      (21,882)



      (47,642)



      (60,910)


      GAAP Net income attributable to Albemarle Corporation

      $

      82,739


      $

      50,089


      $

      166,726


      $

      164,351


      * Excludes corporate noncontrolling interest adjustments of $(23) and $(20) for the three-month and six-month periods ended June 30, 2012, respectively.


      See below for a reconciliation of Net income attributable to Albemarle Corporation excluding special and non-operating pension and OPEB items, EBITDA and EBITDA excluding special and non-operating pension and OPEB items, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP.  EBITDA is defined as Net income attributable to Albemarle Corporation before interest and financing expenses, income taxes, depreciation and amortization.  EBITDA excluding special and non-operating pension and OPEB items is defined as EBITDA before the special and non-operating pension and OPEB items as listed below.


      Three Months Ended


      Six Months Ended



      June 30,


      June 30,



      2013


      2012


      2013


      2012















      Net income attributable to Albemarle Corporation

      $

      82,739


      $

      50,089


      $

      166,726


      $

      164,351















      Add back:













      Non-operating pension and OPEB items (net of tax)


      (947)



      (8,424)



      (2,244)



      (10,127)


      Special items (net of tax)


      —



      73,590



      —



      73,590


      Net income attributable to Albemarle Corporation excluding special













        and non-operating pension and OPEB items

      $

      81,792


      $

      115,255


      $

      164,482


      $

      227,814









































      Net income attributable to Albemarle Corporation

      $

      82,739


      $

      50,089


      $

      166,726


      $

      164,351















      Add back:













      Interest and financing expenses


      7,608



      8,486



      12,839



      17,220


      Income tax expense


      21,450



      21,882



      47,642



      60,910


      Depreciation and amortization


      26,573



      25,214



      51,817



      49,449


      EBITDA


      138,370



      105,671



      279,024



      291,930


      Non-operating pension and OPEB items


      (1,515)



      (13,329)



      (3,584)



      (16,023)


      Special items


      —



      94,703



      —



      94,703


      EBITDA excluding special and non-operating pension and













        OPEB items

      $

      136,855


      $

      187,045


      $

      275,440


      $

      370,610















      Net sales

      $

      634,197


      $

      684,894


      $

      1,275,822


      $

      1,396,598















      EBITDA Margin


      21.8

      %


      15.4

      %


      21.9

      %


      20.9

      %














      EBITDA Margin excluding special and non-operating pension and













        OPEB items


      21.6

      %


      27.3

      %


      21.6

      %


      26.5

      %

      SOURCE Albemarle Corporation

      Modal title

      Also from this source

      Albemarle Reports Third Quarter 2026 Results

      Albemarle Reports Third Quarter 2026 Results

      Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its ...

      Albemarle Announces Quarterly Common Stock Dividend

      Albemarle Announces Quarterly Common Stock Dividend

      The Board of Directors of Albemarle Corporation (NYSE: ALB) today announced that it declared a quarterly common stock dividend of $0.41 per share....

      More Releases From This Source

      Explore

      Chemical

      Chemical

      Mining & Metals

      Mining & Metals

      Oil & Energy

      Oil & Energy

      Utilities

      Utilities

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.